Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: A case report with histological, molecular genetics and long-term tumor cells culture studies

American Journal of Dermatopathology

Volumn 34, Issue 6, 2012, Pages 626-631

  Petrella, Tony ^a,b   Hervé, Geneviève ^a   Bonnotte, Bernard ^a   Girodon, François ^a   Carlson, John Andrew ^c   Bour, Jean Baptiste ^a   Lebon, Pierre ^d   Mugneret, Francine ^a   Callier, Patrick ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b Center of Pathology   (France)

^c ALBANY MEDICAL COLLEGE   (United States)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

alphainterferon; blastic plasmacytoid dendritic cells neoplasm; CD123; CD303; ETV6 gene

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MX 1 PROTEIN; PREDNISONE; PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE;

AGED; ANEMIA; ARTICLE; BLAST CELL; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; BONE MARROW; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 15; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 9; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOKINE RELEASE; DISSEMINATED INTRAVASCULAR CLOTTING; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERFERON PRODUCTION; MALE; MALIGNANT NEOPLASTIC DISEASE; MENINGOENCEPHALIC TUBERCULOSIS; MENINGOENCEPHALITIS; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURPURA; SKIN BIOPSY; SKIN NODULE; THROMBOCYTOPENIA; TUBERCULOUS MENINGITIS;

AGED, 80 AND OVER; COMPARATIVE GENOMIC HYBRIDIZATION; DENDRITIC CELLS; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; KARYOTYPE; LYMPHOMA; MALE; SKIN NEOPLASMS; TRANSCRIPTOME; TUMOR CELLS, CULTURED;

EID: 84864328869     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31824d689c     Document Type: Article

References (19)

1. Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Tumors WHOCo, ed. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:145-147.
2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785. (Pubitemid 40656118)
3. Jaffe ES, Ralfkiaer E. Mature T-cell and NK-cell neoplasms. In: Tumors WHOCo, ed. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 3rd ed. Lyon, France: IARC press; 2001: 191-235.
4. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): A review. Am J Clin Pathol. 2005;123:662-675. (Pubitemid 40586484)
5. Marafioti T, Paterson JC, Ballabio E, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood. 2008;111:3778-3792.
6. Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: What do we know in 2009? Autoimmunity. 2010;43:210-214.
7. Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: Physiologic roles and pathologic states. Adv Anat Pathol. 2009;16:392-404.
8. Haller O, Staeheli P, Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie. 2007;89:812-818. (Pubitemid 47001645)
9. Diop OM, Ploquin MJ, Mortara L, et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol. 2008;82: 5145-5152. (Pubitemid 351705223)
10. Petrella T, Dalac S, Maynadie M, et al. CD4+ CD56+ cutaneous neoplasms: A distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol. 1999;23:137-146.
11. Leroux D, Mugneret F, Callanan M, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: A study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood. 2002;99:4154-4159. (Pubitemid 35332060)
12. Dijkman R, van Doorn R, Szuhai K, et al. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood. 2007;109:1720-1727. (Pubitemid 46239607)
13. Jardin F, Callanan M, Penther D, et al. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease. Leukemia. 2009;23:698-707.
14. Wiesner T, Obenauf AC, Cota C, et al. Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol. 2010;130:1152-1157.
15. Lucioni M, Novara F, Fiandrino G, et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011;118:4591-4594.
16. Bohlander SK. ETV6: A versatile player in leukemogenesis. Semin Cancer Biol. 2005;15:162-174.
17. Maeda T, Murata K, Fukushima T, et al. A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma. Int J Hematol. 2005;81:148-154. (Pubitemid 40270988)
18. Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001;97:3210-3217.
19. Fenaux P, Jouet JP, Zandecki M, et al. Chronic and subacute myelomonocytic leukaemia in the adult: A report of 60 cases with special reference to prognostic factors. Br J Haematol. 1987;65:101-106. (Pubitemid 17234319)